Literature DB >> 2187048

Gonadotrophin glycosylation and function.

C A Wilson1, A J Leigh, A J Chapman.   

Abstract

This review emphasizes the heterogeneous structure of the gonadotrophin hormones and the influence of different oligosaccharide structures on the bioactivity of these hormones. A summary has been made of the changes in biopotency of the gonadotrophins throughout the life-cycle of the human and in different endocrine states in the rat. In general it appears that the charge of the gonadotrophin conferred by the acid radicals attached to the terminal groups on the oligosaccharide structures strongly influences biopotency. Basic structures have a greater potency in in-vitro assays, but a short half-life in the circulation, while acidic isoforms are less potent, but have a longer circulatory time and are thus more active in in-vivo estimations. More basic forms are secreted over the adult reproductive years compared with the prepubertal period and old age. The glycosyl structure of the carbohydrate groups also alters in different endocrine states and is probably also important for the bioactivity and potency of the hormone. Gonadotrophin-releasing hormone (GnRH) and gonadal steroids can influence the type of isoform synthesized and released, and therefore affect the function of gonadotrophins. GnRH enhances glycosylation, sulphation and biopotency. Oestradiol potentiates the glycosylation induced by GnRH and reduces sialylation, while testosterone increases sialylation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187048     DOI: 10.1677/joe.0.1250003

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems: implications for the structure-function relationship of the FSH variants.

Authors:  E Zambrano; T Zariñán; A Olivares; J Barrios-de-Tomasi; A Ulloa-Aguirre
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

Review 2.  Molecular regulation of follicle-stimulating hormone synthesis, secretion and action.

Authors:  Nandana Das; T Rajendra Kumar
Journal:  J Mol Endocrinol       Date:  2018-02-07       Impact factor: 5.098

3.  Gonadotropin evaluation in the diagnosis of polycystic ovary syndrome using either a monoclonal or a polyclonal antibody radioimmunoassay.

Authors:  C Manieri; R Pastorino; A R Marolda; M C Musso; A Gellona; A Barberis; G Boggio; M Messina
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

4.  Role of ribosomal protein L12 in gonococcal invasion of Hec1B cells.

Authors:  J M Spence; V L Clark
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 5.  Environmental endocrine disruption: an effects assessment and analysis.

Authors:  T M Crisp; E D Clegg; R L Cooper; W P Wood; D G Anderson; K P Baetcke; J L Hoffmann; M S Morrow; D J Rodier; J E Schaeffer; L W Touart; M G Zeeman; Y M Patel
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

6.  Effects of 17beta-oestradiol and norethisterone acetate on sulfonation and sialylation of gonadotrophins in post-menopausal women.

Authors:  Leif Wide; Tord Naessén; Karin Eriksson
Journal:  Ups J Med Sci       Date:  2010-05       Impact factor: 2.384

7.  Polymorphism of thyrotropin and alpha subunit in human pituitary adenomas.

Authors:  I Sergi; G Medri; M J Papandreou; G Gunz; P Jaquet; C Ronin
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

Review 8.  Pesticide exposure: the hormonal function of the female reproductive system disrupted?

Authors:  Reini W Bretveld; Chris M G Thomas; Paul T J Scheepers; Gerhard A Zielhuis; Nel Roeleveld
Journal:  Reprod Biol Endocrinol       Date:  2006-05-31       Impact factor: 5.211

9.  Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.

Authors:  Nienke S Weiss; Elena Kostova; Marleen Nahuis; Ben Willem J Mol; Fulco van der Veen; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2019-01-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.